Subcutaneously applied magnesium protects reliably against quinolinate-induced (NMDA)-mediated neurodegeneration and convulsions in rats: Are there therapeutical implications?
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 117 (1-2) , 207-211
- https://doi.org/10.1016/0304-3940(90)90145-y
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Quinolinate neurotoxicity and glutamatergic structuresNeuroscience, 1990
- Selective vulnerability of synaptic transmission in hippocampus to ex-vivo ischemia: effects of extracellular ionic substitution in the postischemic periodBrain Research, 1989
- Ictal epileptiform events induced by removal of extracellular magnesium in slices of entorhinal cortex are blocked by baclofenExperimental Neurology, 1989
- Magnesium protects against neurological deficit after brain injuryBrain Research, 1989
- Taking apart NMDA receptorsNature, 1987
- Ionic requirements for neurotoxic effects of excitatory amino acid analogues in rat cerebellar slicesNeuroscience, 1986
- Magnesium ions block an N-methyl-d-aspartate receptor-mediated component of synaptic transmission in rat hippocampusNeuroscience Letters, 1985
- Magnesium gates glutamate-activated channels in mouse central neuronesNature, 1984
- Mechanisms involved in irreversible anoxic damage to the in vitro rat hippocampal sliceThe Journal of Physiology, 1982
- Selective depression of excitatory amino acid induced depolarizations by magnesium ions in isolated spinal cord preparations.The Journal of Physiology, 1980